Xenon Pharmaceuticals
XENE
$40.10
Share price
1.52%
Change (1 day)
2.14%
Change (1 year)
Categories
Earnings for Xenon Pharmaceuticals (XENE)
Earnings in 2023 (TTM): -$0.22 B
According to Xenon Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.22 B. In 2022 the company made an earning of -$0.13 B a decrease over its 2021 earnings that were of -$79.24 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Xenon Pharmaceuticals from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.22 B | 70.89% |
| 2022 | -$0.13 B | 58.08% |
| 2021 | -$79.24 M | 176.95% |
| 2020 | -$28.61 M | -28.8% |
| 2019 | -$40.19 M | 21.38% |
| 2018 | -$33.11 M | 4.53% |
| 2017 | -$31.68 M | 27.63% |
| 2016 | -$24.82 M | 165.11% |
| 2015 | -$9.37 M | -176.14% |
| 2014 | $12.29 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Coherus BioSciences
CHRS | -$0.2 B | -7.63% | 🇺🇸 USA |
 Atara Biotherapeutics ATRA | -$0.28 B | 26.52% | 🇺🇸 USA |